相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cetuximab/C225-Induced Intracellular Trafficking of Epidermal Growth Factor Receptor
Hong-Jun Liao et al.
CANCER RESEARCH (2009)
Toxicity of Targeted Therapy in Non-Small-Cell Lung Cancer Management
Serena Ricciardi et al.
CLINICAL LUNG CANCER (2009)
ErbB receptors and signaling pathways in cancer
Nancy E. Hynes et al.
CURRENT OPINION IN CELL BIOLOGY (2009)
Technical and Biological Issues Relevant to Cell Typing with Aptamers
Na Li et al.
JOURNAL OF PROTEOME RESEARCH (2009)
Systemic administration of optimized aptamer-siRNA chimeras promotes regression of PSMA-expressing tumors
Justin P. Dassie et al.
NATURE BIOTECHNOLOGY (2009)
Therapeutic Applications of DNA and RNA Aptamers
Kristina W. Thiel et al.
OLIGONUCLEOTIDES (2009)
Binding of cetuximab to the EGFRvIII deletion mutant and its biological consequences in malignant glioma cells
Barry Jutten et al.
RADIOTHERAPY AND ONCOLOGY (2009)
Anti-EGFR Therapy: Mechanism and Advances in Clinical Efficacy in Breast Cancer
John F. Flynn et al.
JOURNAL OF ONCOLOGY (2009)
Aptamer-targeted gold nanoparticles as molecular-specific contrast agents for reflectance imaging
David J. Javier et al.
BIOCONJUGATE CHEMISTRY (2008)
Current aspects of targeted therapy in head and neck tumors
Andreas Dietz et al.
EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY (2008)
Identification of RNA sequence motifs stimulating sequence-specific TLR8-dependent immune responses
Alexandra Forsbach et al.
JOURNAL OF IMMUNOLOGY (2008)
Novel dual inhibitory function aptamer-siRNA delivery system for HIV-1 therapy
Jiehua Zhou et al.
MOLECULAR THERAPY (2008)
Drug therapy: EGFR antagonists in cancer treatment
Fortunato Ciardiello et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Aptamers that recognize drug-resistant HIV-1 reverse transcriptase
Na Li et al.
NUCLEIC ACIDS RESEARCH (2008)
Aptamer-based endocytosis of a lysosomal enzyme
Chi-hong B. Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
SELEX-A (r)evolutionary method to generate high-affinity nucleic acid ligands
Regina Stoltenburg et al.
BIOMOLECULAR ENGINEERING (2007)
The epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor AG1478 increases the formation of inactive untethered EGFR dimers - Implications for combination therapy with monoclonal antibody 806
Hui K. Gan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Effect of the anti-receptor ligand-blocking 225 monoclonal antibody on EGF receptor endocytosis and sorting
Maria L. Jaramillo et al.
EXPERIMENTAL CELL RESEARCH (2006)
Cell type-specific delivery of siRNAs with aptamer-siRNA chimeras
James O. McNamara et al.
NATURE BIOTECHNOLOGY (2006)
Aptamer:toxin conjugates that specifically target prostate tumor cells
Ted C. Chu et al.
CANCER RESEARCH (2006)
Epidermal growth factor receptor (EGFR) signaling in cancer
N Normanno et al.
GENE (2006)
Aptamer mediated siRNA delivery
Ted C. Chu et al.
NUCLEIC ACIDS RESEARCH (2006)
An aptamer-doxorubicin physical conjugate as a novel targeted drug-delivery platform
Vaishali Bagalkot et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2006)
Structural basis for inhibition of the epidermal growth factor receptor by cetuximab
SQ Li et al.
CANCER CELL (2005)
Sequence-dependent stimulation of the mammalian innate immune response by synthetic siRNA
AD Judge et al.
NATURE BIOTECHNOLOGY (2005)
Neutralizing aptamers from whole-cell SELEX inhibit the RET receptor tyrosine kinase
L Cerchia et al.
PLOS BIOLOGY (2005)
Fully 2′-modified oligonucleotide duplexes with improved in vitro potency and stability compared to unmodified small interfering RNA
CR Allerson et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
In vivo activity of nuclease-resistant siRNAs
JM Layzer et al.
RNA (2004)
Interferon induction by siRNAs and ssRNAs synthesized by phage polymerase
DH Kim et al.
NATURE BIOTECHNOLOGY (2004)
Therapeutic antibodies
B Groner et al.
CURRENT MOLECULAR MEDICINE (2004)
Nanopartide-aptamer bioconjugates: A new approach for targeting prostate cancer cells
OC Farokhzad et al.
CANCER RESEARCH (2004)
Active and inactive conformations of the epidermal growth factor receptor
KM Ferguson
BIOCHEMICAL SOCIETY TRANSACTIONS (2004)
Neutralization of infectivity of diverse R5 clinical isolates of human immunodeficiency virus type 1 by gp120-binding 2′F-RNA aptamers
M Khati et al.
JOURNAL OF VIROLOGY (2003)
Inhibition of heregulin signaling by an aptamer that preferentially binds to the oligomeric form of human epidermal growth factor receptor-3
CHB Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Crystal structure of the complex of human epidermal growth factor and receptor extracellular domains
H Ogiso et al.
CELL (2002)
The EGF receptor family as targets for cancer therapy
J Mendelsohn et al.
ONCOGENE (2000)
Developing aptamers into therapeutics
RR White et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
分享论文
